A. Lánczky

Cancer Research · 2010–2021

A researcher in the Science corpus: 7 papers; trusts 6 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom A. Lánczky trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Balázs Győrffy
  2. Laurent Gautier
  3. Zoltan Szallasi
  4. Marilena V. Iorio
  5. Leslie M. Cope

Who trusts A. Lánczky overall

  1. Balázs Győrffy
  2. Matan Hofree

Papers from A. Lánczky's perspective

Ordered by how strongly the researchers A. Lánczky trusts endorse each paper. Same corpus, a different order for every researcher.

  1. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. (New England Journal of Medicine)
  2. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. (Journal of Clinical Oncology)
  3. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. (Journal of Clinical Oncology)
  4. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 (Annals of Oncology)
  5. Evaluation of gene expression measurements from commercial microarray platforms. (Nucleic Acids Research)
  6. American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer. (Journal of Oncology Practice)
  7. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer (Theranostics)
  8. affy - analysis of Affymetrix GeneChip data at the probe level (Bioinform.)
  9. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements (Nature Biotechnology)
  10. Reliability and reproducibility issues in DNA microarray measurements. (Trends in Genetics)

Their papers